Ergoteles LLC Contrafect Corp Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.09 - $0.19 $3,617 - $7,636
40,192 New
40,192 $4,000
Q4 2021

Feb 14, 2022
SELL
$2.47 - $4.14 $185,459 - $310,851
-75,085 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.19 - $4.43 $5,151 - $7,154
-1,615 Reduced 2.11%
75,085 $304,000
Q2 2021

Aug 12, 2021
BUY
$3.58 - $4.9 $274,586 - $375,830
76,700 New
76,700 $337,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email